232 related articles for article (PubMed ID: 7887827)
1. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
[TBL] [Abstract][Full Text] [Related]
2. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
[TBL] [Abstract][Full Text] [Related]
3. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators.
Ashraf S; Tian Y; Cowan D; Entress A; Martin PG; Watterson KG
Ann Thorac Surg; 1997 Dec; 64(6):1790-4. PubMed ID: 9436574
[TBL] [Abstract][Full Text] [Related]
4. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a silicone coated hollow fiber oxygenator.
Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
[TBL] [Abstract][Full Text] [Related]
6. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass.
Kagisaki K; Masai T; Kadoba K; Sawa Y; Nomura F; Fukushima N; Ichikawa H; Ohata T; Suzuki K; Taketani S; Matsuda H
Artif Organs; 1997 Jul; 21(7):836-40. PubMed ID: 9212969
[TBL] [Abstract][Full Text] [Related]
7. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
[TBL] [Abstract][Full Text] [Related]
9. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators.
Gu YJ; Boonstra PW; Graaff R; Rijnsburger AA; Mungroop H; van Oeveren W
Artif Organs; 2000 Jan; 24(1):43-8. PubMed ID: 10677156
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
[TBL] [Abstract][Full Text] [Related]
11. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
13. Disadvantages of prostacyclin infusion during cardiopulmonary bypass: a double-blind study of 50 patients having coronary revascularization.
DiSesa VJ; Huval W; Lelcuk S; Jonas R; Maddi R; Lee-Son S; Shemin RJ; Collins JJ; Hechtman HB; Cohn LH
Ann Thorac Surg; 1984 Nov; 38(5):514-9. PubMed ID: 6388516
[TBL] [Abstract][Full Text] [Related]
14. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
Horimoto H; Kondo K; Asada K; Sasaki S
Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
[TBL] [Abstract][Full Text] [Related]
15. Blood conservation with membrane oxygenators and dipyridamole.
Teoh KH; Christakis GT; Weisel RD; Madonik MM; Ivanov J; Wong PY; Mee AV; Levitt D; Benak A; Reilly P
Ann Thorac Surg; 1987 Jul; 44(1):40-7. PubMed ID: 3300583
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass.
Shimamoto A; Kanemitsu S; Fujinaga K; Takao M; Onoda K; Shimono T; Tanaka K; Shimpo H; Yada I
Ann Thorac Surg; 2000 Jan; 69(1):115-20. PubMed ID: 10654498
[TBL] [Abstract][Full Text] [Related]
17. The influence of a heparin-coated oxygenator during cardiopulmonary bypass on postoperative lung oxygenation capacity in pediatric patients with congenital heart anomalies.
Watanabe H; Miyamura H; Hayashi J; Ohzeki H; Sugawara M; Takahashi Y; Eguchi S
J Card Surg; 1996; 11(6):396-401. PubMed ID: 9083864
[TBL] [Abstract][Full Text] [Related]
18. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig.
Nilsson L; Storm KE; Thelin S; Bagge L; Hultman J; Thorelius J; Nilsson U
Artif Organs; 1990 Feb; 14(1):46-8. PubMed ID: 2302076
[TBL] [Abstract][Full Text] [Related]
19. Effect of Carmeda BioActive Surface coating versus Trillium Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass.
Palanzo DA; Zarro DL; Manley NJ; Montesano RM; Quinn M; Elmore BA; Gustafson PA; Castagna JM
Perfusion; 2001 Jul; 16(4):279-83. PubMed ID: 11486846
[TBL] [Abstract][Full Text] [Related]
20. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.
van den Goor J; Nieuwland R; van den Brink A; van Oeveren W; Rutten P; Tijssen J; Eijsman L
Eur J Cardiothorac Surg; 2004 Nov; 26(5):926-31. PubMed ID: 15519184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
